Dobrin Svinarov

934 total citations
53 papers, 686 citations indexed

About

Dobrin Svinarov is a scholar working on Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Dobrin Svinarov has authored 53 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 11 papers in Pediatrics, Perinatology and Child Health and 10 papers in Molecular Biology. Recurrent topics in Dobrin Svinarov's work include Vitamin D Research Studies (14 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Analytical Methods in Pharmaceuticals (6 papers). Dobrin Svinarov is often cited by papers focused on Vitamin D Research Studies (14 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Analytical Methods in Pharmaceuticals (6 papers). Dobrin Svinarov collaborates with scholars based in Bulgaria, Germany and France. Dobrin Svinarov's co-authors include Maria Shipkova, Michael Oellerich, Victor W. Armstrong, Eberhard Wieland, Ekkehard Schütz, Srebrena Atanasova, Lilia Dakovska, Jordan Vlahov, Alexander Shinkov and M. G. Aman and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Chromatography A.

In The Last Decade

Dobrin Svinarov

51 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dobrin Svinarov Bulgaria 15 153 151 117 116 107 53 686
Guillaume Hoizey France 16 110 0.7× 220 1.5× 149 1.3× 376 3.2× 58 0.5× 71 997
D W Holt United Kingdom 14 175 1.1× 88 0.6× 113 1.0× 165 1.4× 41 0.4× 48 768
Bernard Vinet Canada 16 97 0.6× 131 0.9× 57 0.5× 130 1.1× 29 0.3× 35 744
Hana Brozmanová Czechia 15 73 0.5× 247 1.6× 149 1.3× 41 0.4× 148 1.4× 65 645
Gary L. Lensmeyer United States 20 180 1.2× 360 2.4× 172 1.5× 150 1.3× 91 0.9× 37 1.6k
Donald F. LeGatt Canada 18 300 2.0× 140 0.9× 209 1.8× 426 3.7× 61 0.6× 60 1.2k
Steven J. Soldin Canada 15 118 0.8× 152 1.0× 105 0.9× 18 0.2× 72 0.7× 22 649
Jean‐Guy Besner Canada 18 174 1.1× 261 1.7× 191 1.6× 402 3.5× 77 0.7× 39 1.1k
E. Mueller Switzerland 17 71 0.5× 127 0.8× 120 1.0× 136 1.2× 65 0.6× 40 881
Sebastiano Barco Italy 18 144 0.9× 134 0.9× 353 3.0× 21 0.2× 32 0.3× 56 870

Countries citing papers authored by Dobrin Svinarov

Since Specialization
Citations

This map shows the geographic impact of Dobrin Svinarov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dobrin Svinarov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dobrin Svinarov more than expected).

Fields of papers citing papers by Dobrin Svinarov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dobrin Svinarov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dobrin Svinarov. The network helps show where Dobrin Svinarov may publish in the future.

Co-authorship network of co-authors of Dobrin Svinarov

This figure shows the co-authorship network connecting the top 25 collaborators of Dobrin Svinarov. A scholar is included among the top collaborators of Dobrin Svinarov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dobrin Svinarov. Dobrin Svinarov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Svinarov, Dobrin, et al.. (2023). Relationship between Vitamin D status and microbiome changes in Bulgarian patients with type 2 diabetes mellitus. Biotechnology & Biotechnological Equipment. 37(1). 5 indexed citations
4.
Bogov, Boris, et al.. (2023). Serum and Urinary Biomarkers in COVID-19 Patients with or without Baseline Chronic Kidney Disease. Journal of Personalized Medicine. 13(3). 382–382. 3 indexed citations
5.
Vlahova, Angelina, et al.. (2022). Development and validation of an LC-MS/MS method for determination of 8-iso-prostaglandin f2 Alpha in human saliva. Journal of Medical Biochemistry. 41(4). 466–473. 7 indexed citations
6.
Svinarov, Dobrin, et al.. (2021). Evaluation of automated hematology analyzer DYMIND DH76 compared to SYSMEX XN 1000 system. Journal of Medical Biochemistry. 40(4). 367–377. 2 indexed citations
7.
Bocheva, Georgeta, et al.. (2020). Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS. Journal of Medical Biochemistry. 40(1). 10–16. 6 indexed citations
8.
Shipkova, Maria & Dobrin Svinarov. (2016). LC–MS/MS as a tool for TDM services: Where are we?. Clinical Biochemistry. 49(13-14). 1009–1023. 60 indexed citations
9.
Dimitrovska, Aneta, et al.. (2016). High-Throughput HPLC-MS/MS Method for Quantification of Ibuprofen Enantiomers in Human Plasma: Focus on Investigation of Metabolite Interference. Journal of Chromatographic Science. 54(10). 1820–1826. 6 indexed citations
10.
Shinkov, Alexander, et al.. (2015). Dynamic of the seasonal levels of 25(OH)D in Bulgaria according to sex, age and winter status of vitamin D. 3(2-4). 107–113. 1 indexed citations
11.
Galunska, Bistra, et al.. (2015). PREVALENCE OF VITAMIN D DEFICIENCY IN DIFFERENT GROUPS OF CHRONIC RENAL FAILURE PATIENTS. SHILAP Revista de lepidopterología. 21(3). 887–890. 2 indexed citations
12.
Svinarov, Dobrin, et al.. (2015). Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients. Biotechnology & Biotechnological Equipment. 29(2). 331–335. 37 indexed citations
13.
Svinarov, Dobrin, et al.. (2014). Seasonal variations of 25-hydroxyvitamin D in Bulgarian kidney transplant recipients.. 50(3). 37–41.
14.
Svinarov, Dobrin, et al.. (2013). VITAMIN D STATUS IN PATIENTS WITH KIDNEY TRANSPLANTATION. 49(1). 16–19. 1 indexed citations
15.
Shinkov, Alexander, et al.. (2013). Vitamin D status in Bulgaria—winter data. Archives of Osteoporosis. 8(1-2). 133–133. 18 indexed citations
16.
17.
Shipkova, Maria, Srebrena Atanasova, P. D. Niedmann, et al.. (2003). Determination of Thiopurine Methyltransferase Phenotype in Isolated Human Erythrocytes Using a New Simple Nonradioactive HPLC Method. Therapeutic Drug Monitoring. 25(5). 637–644. 17 indexed citations
18.
Atanasova, Srebrena, et al.. (2003). Phenotypic and Genotypic Analysis of Thiopurine S-Methyltransferase Polymorphism in the Bulgarian Population. Therapeutic Drug Monitoring. 25(5). 631–636. 36 indexed citations
19.
Flarakos, Jimmy, et al.. (2003). Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography–mass spectrometry. Journal of Chromatography A. 1026(1-2). 175–183. 41 indexed citations
20.
Wieland, Eberhard, Maria Shipkova, Ekkehard Schütz, et al.. (2001). Preliminary report on the effect of xenoperfusion with human blood on cyclosporin A metabolism and cytochrome-P-4503A4-mRNA expression in a pig liver perfusion model. Clinical Biochemistry. 34(1). 53–57. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026